FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Aug 30, 2019
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on August 30, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Cara M. Minelli (Issuing Officer)
View Company Profile
ID · 9b1713cd-f4d4-4f81-991a-a6717a6a1222
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1101080
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 630.10(e)Medical History Interview
- 21 CFR 630.10(c)Donor Eligibility on day of donation
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.171Biological product deviation report
- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
- 21 CFR 606.100(b)SOPs for investigations, records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 13, 2017 | Not classified | Philadelphia District Office |
Other documents for CSL Plasma Inc.
- FDA Inspection 1159182 - 2021-11-15
- FDA Inspection 1007229 - 2017-04-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.